7 DIFFERENT VEHICLES
1 BEST-SELLING BRAND.*
Acne, Rosacea, Seborrheic Dermatitis.
Whatever my skin throws at me, my dermatologist has me covered.
THE AVAR® LINE OF PRODUCTS
The #1 Branded Sodium Sulfacetamide
Treatment on the Market†
The AVAR® line of products provides safe and effective treatment of seborrheic dermatitis (SD), acne vulgaris (AV), and acne rosacea (AR). AVAR® products contain sodium sulfacetamide, a sulfonamide antibiotic.
More
vehicles
than all other sodium sulfacetamides + sulfur therapies
Powerful
efficacy
of the clinically proven ingredients sodium sulfacetamindes + sulfur
Low
sulfur
option further reduces odor for enhanced patient acceptance
Low odor
across all 7 AVAR formulations
Promotes peeling
and cell turnover with an effective antibacterial and drying agent
Steroid free
making it more suitable for chronic therapy
Suppresses bacteria
associated with acne, rosacea, and seborrheic dermatitis
AVAR® CLEANSERS
Deep Cleanse
A gentle, effective cleanser that will not bleach clothing or towels. Suitable for patients 12 years of age or older. Available in traditional (sulfur 5%) and LS (low sulfur, 2%) formulations.5, 9
AVAR® Cleanser Prescribing Information >
AVAR® LS Cleanser Prescribing Information >
AVAR® TREATMENTS
Treat with Care
A foaming, rinse-off formulation to treat affected areas after cleansing. Available in traditional (sulfur 5%) and LS (low sulfur, 2%) formulations.4, 8
AVAR® Foam Prescribing Information >
AVAR® LS Foam Prescribing Information >
AVAR® CREAMS
Moisturize to the Max
A cosmetically elegant moisturizer that prevents dryness and reduces the redness of rosacea. Available in traditional (sulfur 5%) and LS (low sulfur, 2%) formulations.2,6,10
AVAR-e® Emollient Cream Prescribing Information >
AVAR-e® LS Emollient Cream Prescribing Information >
AVAR-e GREEN® CREAM
Get the Red Out
All the benefits of AVAR-e Green® (sulfur 5%) emollient cream, specially formulated to reduce the red appearance of rosacea. Contains an odor inhibitor.2,11
THE #1
BRANDED
SODIUM
SULFACETAMIDE
TREATMENT ON
THE MARKET†
† Of sodium sulfacetamide + sulfur medications, according to Source Healthcare Analytics PHAST Prescription data, accessed March 2016.